Posts by: Stacy Grieve, PhD

News

Discontinuing Gilenya (fingolimod) treatment and starting on rituximab therapy may be more complicated than originally thought. A new report chronicles the medical journey of a man ... Read more

August 9, 2018September 11, 2018

Low-dose Botox Treatment Improves Urinary Symptoms in MS Patients, Study Finds

News

Results from a Phase 3 clinical trial show that urinary symptoms can be reduced significantly after treatment with low-dose Botox (100 units) in patients with multiple sclerosis ... Read more

August 7, 2018August 9, 2018

Smoking Increases Relapse Rate in RRMS Patients on Tysabri, Study Suggests

News

Smoking increases the relapse rate in patients with relapsing-remitting multiple sclerosis being treated with Tysabri , an observational study suggests. Multiple sclerosis is a multifactorial disease ... Read more

July 10, 2018July 13, 2018

Plenty of Sunlight, Fruits and Coffee Linked to Lower MS Risk in Study of Adults in Saudi Arabia

News

Getting plenty of sun, eating fresh fruits regularly and drinking coffee daily are associated with a lower risk for multiple sclerosis (MS) among adults in Saudi ... Read more

April 12, 2018April 12, 2018

First Generation Disease-modifying Therapies Pose Low Infection Risk in MS, Study Finds

News

A large group study showed that first-generation disease-modifying therapies (DMTs) do not increase the infection risk in multiple sclerosis (MS) patients. Many of the DMTs used ... Read more

September 29, 2017October 3, 2017

Falls Common Among Wheelchair, Scooter Users in People with MS, Study Reports

News

The majority of people living with multiple sclerosis who use wheelchairs or scooters for mobility reported falling at least once over a six-month period, according to ... Read more

August 8, 2017August 8, 2017

Hereditary Gene Mutations Can Be Corrected, Reports Landmark Embryo Study, with Implications for MS

News

For the first time, scientists have shown they can correct gene mutations in human embryos — a breakthrough with implications for multiple sclerosis (MS) and several ... Read more

July 11, 2017July 17, 2017

Long-term Use of Ampyra Lowers Medical Costs, Hospital Visits for MS Patients, Study Finds

News

A recent study has found that continued use of Ampyra (dalfampridine extended-release, sold in the U.S. by Acorda Therapeutics) by patients with multiple sclerosis (MS) lowers ... Read more

March 23, 2017March 23, 2017

Early Rebif Treatment Prolongs Progression to Clinically Definite MS, Study Reports

News

An extension of a Phase 3 clinical trial has shown that early treatment with Rebif (interferon beta-1a) in patients with initial manifestations of multiple sclerosis (MS) ... Read more

Posts by: Stacy Grieve, PhD

Stacy Grieve, PhD

Case Study Suggests Need for New Treatment Strategy When Switching from Gilenya to Rituximab

Low-dose Botox Treatment Improves Urinary Symptoms in MS Patients, Study Finds

Smoking Increases Relapse Rate in RRMS Patients on Tysabri, Study Suggests

Plenty of Sunlight, Fruits and Coffee Linked to Lower MS Risk in Study of Adults in Saudi Arabia

First Generation Disease-modifying Therapies Pose Low Infection Risk in MS, Study Finds

Falls Common Among Wheelchair, Scooter Users in People with MS, Study Reports

Hereditary Gene Mutations Can Be Corrected, Reports Landmark Embryo Study, with Implications for MS

Long-term Use of Ampyra Lowers Medical Costs, Hospital Visits for MS Patients, Study Finds

Early Rebif Treatment Prolongs Progression to Clinically Definite MS, Study Reports

Pin It on Pinterest